For: | Ghaziani T, Sendi H, Shahraz S, Zamor P, Bonkovsky HL. Hepatitis B and liver transplantation: Molecular and clinical features that influence recurrence and outcome. World J Gastroenterol 2014; 20(39): 14142-14155 [PMID: 25339803 DOI: 10.3748/wjg.v20.i39.14142] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i39/14142.htm |
Number | Citing Articles |
1 |
|
2 |
Peter Schemmer, Patrizia Burra, Rey‐Heng Hu, Christian M. Hüber, Carmelo Loinaz, Keigo Machida, Arndt Vogel, Didier Samuel. State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post‐liver transplantation and resection. Liver International 2022; 42(2): 288 doi: 10.1111/liv.15124
|
3 |
Miguel Jiménez-Pérez, Rocío González-Grande, José Mostazo Torres, Carolina González Arjona, Francisco Javier Rando-Muñoz. Management of hepatitis B virus infection after liver transplantation. World Journal of Gastroenterology 2015; 21(42): 12083-12090 doi: 10.3748/wjg.v21.i42.12083
|
4 |
Jessica M Sido, Prakash S Nagarkatti, Mitzi Nagarkatti. Δ9-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells. Journal of Leukocyte Biology 2015; 98(3): 435 doi: 10.1189/jlb.3A0115-030RR
|
5 |
Afroditi Orfanidou, George V. Papatheodoridis, Evangelos Cholongitas. Antiviral prophylaxis against hepatitis B recurrence after liver transplantation: Current concepts. Liver International 2021; 41(7): 1448 doi: 10.1111/liv.14860
|
6 |
Di Lu, Jianyong Zhuo, Modan Yang, Chao Wang, Linhui Pan, Haiyang Xie, Xiao Xu, Shusen Zheng. The association between donor genetic variations in one-carbon metabolism pathway genes and hepatitis B recurrence after liver transplantation. Gene 2018; 663: 121 doi: 10.1016/j.gene.2018.03.071
|
7 |
Mariana Mihăilă, Cristina Mădălina Pascu, Andreea Andrunache, Cătălin Ștefan Ghenea. Antiviral Strategies in the Treatment of Human and Animal Viral Infections. Infectious Diseases 2023; 27 doi: 10.5772/intechopen.112502
|
8 |
Bruno Roche, Anne Marie Roque-Afonso, Frederik Nevens, Didier Samuel. Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation. Transplantation 2015; 99(7): 1321 doi: 10.1097/TP.0000000000000777
|
9 |
Wei Jiang, John L. Farber. Contemporary Liver Transplantation. 2017; : 355 doi: 10.1007/978-3-319-07209-8_21
|
10 |
|
11 |
Wei Jiang, John L. Farber. Contemporary Liver Transplantation. 2016; : 1 doi: 10.1007/978-3-319-05543-5_21-2
|
12 |
Sahar Janfeshan, Ramin Yaghobi, Akram Eidi, Mohammad Hossein Karimi, Bita Geramizadeh, Seyed Ali Malekhosseini, Farshid Kafilzadeh. Study the Cross-talk Between Hepatitis B Virus Infection and Interferon Regulatory Factors in Liver Transplant Patients. Hepatitis Monthly 2017; 17(11) doi: 10.5812/hepatmon.12426
|
13 |
Hesham E. Eldin, Reham E. AlSwaff, Eslam Safwat, Moez M. El Imam. Serum adiponectin in Egyptian patients with chronic hepatitis B virus infection. Egyptian Liver Journal 2018; 8(2): 45 doi: 10.1097/01.ELX.0000547794.42254.91
|
14 |
Roberto Patron, Shimon Kusne, David Mulligan. Transplant Infections. 2016; : 215 doi: 10.1007/978-3-319-28797-3_14
|
15 |
A.J. Demetris, C.O.C. Bellamy, C.R. Gandhi, S. Prost, Y. Nakanuma, D.B. Stolz. Functional Immune Anatomy of the Liver—As an Allograft. American Journal of Transplantation 2016; 16(6): 1653 doi: 10.1111/ajt.13749
|
16 |
Ying Ma, Yujun Yuan, Xianglin Ma, Boru Tang, Ximei Hu, Juan Feng, Li Tian, Yaohua Ji, Xiaoguang Dou. Association between clinical features and YMDD mutations in patients with chronic hepatitis B following lamivudine therapy. Experimental and Therapeutic Medicine 2016; 12(2): 847 doi: 10.3892/etm.2016.3365
|
17 |
Wei Jiang, John L. Farber. Contemporary Liver Transplantation. 2016; : 1 doi: 10.1007/978-3-319-05543-5_21-1
|